UCB's Global Corporate Website
Welcome to UCB in the United States

May

23

Supporting STEM in North Carolina

Wake County, NC teachers visiting for UCB’s annual SummerSTEM day. (L to R) Andrew Oliver, Bruce Mamel, Michelle Woods, Sarah Brown, Ken Whisler, Cherilyn Murray, Antwanna Pegues Simmons, and Laura Williford.

At UCB, we are committed to accelerating scientific discoveries by supporting innovation — leading to the discovery of new solutions that help patients achieve their goals. As part this commitment, we believe it is important to support STEM education in our local communities to help inspire the next generation of scientists.

May

12

New Open Innovation Challenge to Rethink Post-Fracture Care

This Osteoporosis Awareness Month, UCB is pleased to collaborate with OpenIDEO , an open innovation platform, to launch the new Healthy Bones, Healthy Aging Challenge.

May

10

AGA IBD Parenthood Project provides guidance about pregnancy for women with IBD and their health care team

A key underserved patient population is women of childbearing age managing chronic conditions. In honor of Mother’s Day, Aimee Frank, Senior Director of Communications at the American Gastroenterological Association (AGA), shares about the IBD Parenthood Project, an effort led by the AGA with support by UCB, to help address the misperceptions women with inflammatory bowel disease and their healthcare providers experience throughout family planning.

May

03

Disease Spotlight: Non-Radiographic Axial Spondyloarthritis

UCB is committed to improving care and outcomes for patients across the axial spondyloarthritis spectrum of disease. So, for Spondyloarthritis Awareness Month, we’re shining a spotlight on Non-Radiographic Axial Spondyloarthritis (nr-axSpA).

May

02

UCB Flies in to DC to Advocate for Innovation

Earlier this week, researchers from across UCB met in Washington, D.C. for the PhRMA Researcher Fly-In. While on Capitol Hill, the UCB team visited the offices of Representatives Doug Collins, Lucy McBath, and David Price, and Senators Johnny Isakson, Richard Burr, and Thom Tillis and walked their staff through the 15-year journey (on average) of how a new medicine is discovered, developed, and delivered at UCB. Each researcher, representing a different part of the drug development process, shared their personal stories about why they’re motivated each day to continue to innovate for patients.

Apr

22

Advancing Our Green Strategy for the Future

We believe our ability to continue to innovate and create value for patients now and in the future will increasingly depend on our positive contributions to environmental sustainability.

Mar

20

Championing STEM Education for Tomorrow’s Discoveries

At UCB, we are inspired by patients and driven by science to deliver what patients value. We are committed to continuously working to advance science and embrace new knowledge — leading to the discovery of new solutions that help patients achieve their goals.

Mar

13

Driving Our Patient Value Strategy for the Future

2018 marked the 90th anniversary of UCB. Since our creation in 1928, UCB has been characterized by a strong entrepreneurial spirit, determination and resilience, long term views, and a strong belief science and innovation would improve humanity.

Feb

28

Welcoming AAD to Washington, D.C.

We’re excited to welcome the 2019 American Academy of Dermatology (AAD) meeting to Washington, D.C. this week. As AAD comes to town, we wanted to offer a few recommendations from our D.C. staff. UCB’s D.C. office focuses on public policy with colleagues in advocacy, policy, public affairs, and regulatory.

Feb

27

It’s Not Because It’s ‘Rare’ that We Care

For International Rare Disease Day, our Global Head of the Rozimab Mission, Chris Clark, shares insights about how UCB is leveraging and growing our capabilities to deliver value for specific patient populations new to UCB. Read the full article on LinkedIn.